Sinovac Biotech&Rite Aid Corporation Review: (NASDAQ: SVA), (NYSE: RAD)
Sinovac Biotech Ltd. (NASDAQ: SVA) announced preliminary top-line data from its Phase III clinical trial assessing the efficacy, immunogenicity and safety of the Company's proprietary Enterovirus 71 vaccine against hand, foot and mouth disease.
View full press release